Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach

Does Rejection Hurt? An fMRI Study of Social Exclusion

Eisenberger, N. I., Lieberman, M. D., & Williams, K. D. (2003) · Science · doi:10.1126/science.1089134 · Cited by 3,849 · see citing works

Neurobiology of Depression

Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217 · see citing works

Subgenual prefrontal cortex abnormalities in mood disorders

Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693 · see citing works

Bayesian Theory

Bernardo, J. M., & Smith, A. F. M. (1994) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316870 · Cited by 2,178 · see citing works

Advances in Neuropathic Pain

Dworkin, R. H., Bačkonja, M., Rowbotham, M. C., Allen, R. R., Argoff, C., Bennett, G. J., Bushnell, M. C., Farrar, J. T., Galer, B. S., Haythornthwaite, J. A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.11.1524 · Cited by 1,213 · see citing works

Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia

Hakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V., & Fienberg, A. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081071198 · Cited by 1,192 · see citing works

Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication

Chen, B., Dowlatshahi, D., MacQueen, G. M., Wang, J.-F., & Young, L. T. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01083-6 · Cited by 1,164 · see citing works

Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: Schizophrenia

Lewis, C. M., Levinson, D. F., Wise, L. H., DeLisi, L. E., Straub, R. E., Hovatta, I., Williams, N. M., Schwab, S. G., Pulver, A. E., Faraone, S. V., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/376549 · Cited by 1,134 · see citing works

Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.

Tkachev, D., Mimmack, M., Ryan, M. M., Wayland, M., Freeman, T., Jones, P., Starkey, M., Webster, M., Yolken, R., & Bahn, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14289-4 · Cited by 940 · see citing works

Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia

Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1296 · Cited by 914 · see citing works

Altered Gene Expression of Brain-Derived Neurotrophic Factor and Receptor Tyrosine Kinase B in Postmortem Brain of Suicide Subjects

Dwivedi, Y., Rizavi, H. S., Conley, R. R., Roberts, R. C., Tamminga, C. A., & Pandey, G. N. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.8.804 · Cited by 875 · see citing works

The Neurobiology of Slow Synaptic Transmission

Greengard, P. (2001) · Science · doi:10.1126/science.294.5544.1024 · Cited by 865 · see citing works

Tbr1 regulates differentiation of the preplate and layer 6

Hevner, R. F., Shi, L., Justice, N., Hsueh, Y.-P., Sheng, M., Smiga, S., Bulfone, A., Goffinet, A. M., Campagnoni, A. T., & Rubenstein, J. L. R. (2001) · Neuron · doi:10.1016/s0896-6273(01)00211-2 · Cited by 857 · see citing works

Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia

Badner, J. A., & Gershon, E. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001012 · Cited by 811 · see citing works

Altered nociception, analgesia and aggression in mice lacking the receptor for substance P

Felipe, C. D., Herrero, J. F., O’Brien, J., Palmer, J. A., Doyle, C. A., Smith, A. J. H., Laird, J. M. A., Belmonte, C., Cerveró, F., & Hunt, S. P. (1998) · Nature · doi:10.1038/32904 · Cited by 755 · see citing works

Regulation of gene expression and cocaine reward by CREB and ΔFosB

McClung, C. A., & Nestler, E. J. (2003) · Nature Neuroscience · doi:10.1038/nn1143 · Cited by 625 · see citing works

Exploring the opioid system by gene knockout

Kieffer, B. L., & Gavériaux-Ruff, C. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00008-4 · Cited by 620 · see citing works

Gene Expression Profiles in the Brain Predict Behavior in Individual Honey Bees

Whitfield, C. W., Cziko, A.-M., & Robinson, G. E. (2003) · Science · doi:10.1126/science.1086807 · Cited by 618 · see citing works

The Brain-Derived Neurotrophic Factor Gene Confers Susceptibility to Bipolar Disorder: Evidence from a Family-Based Association Study

Neves-Pereira, M., Mundo, E., Muglia, P., King, N. A., Macciardi, F. M., & Kennedy, J. L. (2002) · The American Journal of Human Genetics · doi:10.1086/342288 · Cited by 594 · see citing works

Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part III: Bipolar Disorder

Segurado, R., Detera‐Wadleigh, S. D., Levinson, D. F., Lewis, C. M., Gill, M., Nürnberger, J. I., Craddock, N. J., DePaulo, J. R., Baron, M., Gershon, E. S., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/376547 · Cited by 569 · see citing works

Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus

Sklar, P. B., Gabriel, S., McInnis, M. G., Bennett, P., Lim, Y.-M., Tsan, G., Schaffner, S. F., Kirov, G., Jones, I. R., Owen, M. J., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001058 · Cited by 563 · see citing works

Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons

Bibb, J. A., Snyder, G. L., Nishi, A., Yan, Z., Meijer, L., Fienberg, A. A., Tsai, L., Kwon, Y. T., Girault, J., Czernik, A. J., et al. (1999) · Nature · doi:10.1038/45251 · Cited by 553 · see citing works

Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21

Blouin, J., Dombroski, B. A., Nath, S. K., Lasseter, V. K., Wolyniec, P. S., Nestadt, G., Thornquist, M. H., Ullrich, G., McGrath, J. A., Kasch, L. M., et al. (1998) · Nature Genetics · doi:10.1038/1734 · Cited by 531 · see citing works

Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder

Johnston-Wilson, N. L., Sims, C. D., Hofmann, J.-P., Anderson, L., Shore, A. D., Torrey, E. F., Yolken, R. H., & the Stanley Neuropathology Consortium (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000696 · Cited by 531 · see citing works

Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling

Colangelo, V., Schurr, J., Ball, M. J., Pelaez, R. P., Bazan, N. G., & Lukiw, W. J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10351 · Cited by 517 · see citing works

Neuronal Activity-Dependent Cell Survival Mediated by Transcription Factor MEF2

Mao, Z., Bonni, A., Xia, F., Nadal-Vicens, M. F., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5440.785 · Cited by 505 · see citing works

DARPP-32: Regulator of the Efficacy of Dopaminergic Neurotransmission

Fienberg, A. A., Hiroi, N., Mermelstein, P. G., Song, W., Snyder, G. L., Nishi, A., Chéramy, A., O'Callaghan, J. P., Miller, D. B., Cole, D. G., et al. (1998) · Science · doi:10.1126/science.281.5378.838 · Cited by 491 · see citing works

A Quantitative Study

Ovbiagele, B. I., Kidwell, C. S., & Saver, J. L. (2005) · Cited by 454 · see citing works

Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia

Mirnics, K., Middleton, F. A., Stanwood, G. D., Lewis, D. A., & Levitt, P. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000866 · Cited by 446 · see citing works

Activation and redistribution of c‐Jun N‐terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease

Zhu, X.-W., Raina, A., Rottkamp, C., Aliev, G., Perry, G., Boux, H., & Smith, M. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00046.x · Cited by 440 · see citing works

Neuropsychopharmacology

Fleischhacker, W. W., & Brooks, D. J. (2003) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6020-6 · Cited by 439 · see citing works

Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia

Hof, P. R., Haroutunian, V., Friedrich, V. L., Byne, W., Buitron, C., Perl, D. P., & Davis, K. L. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00237-3 · Cited by 433 · see citing works

Genomewide Genetic Linkage Analysis Confirms the Presence of Susceptibility Loci for Schizophrenia, on Chromosomes 1q32.2, 5q33.2, and 8p21-22 and Provides Support for Linkage to Schizophrenia, on Chromosomes 11q23.3-24 and 20q12.1-11.23

Gurling, H., Kalsi, G., Brynjolfsson, J., Sigmundsson, T., Sherrington, R. P., Mankoo, B. S., Read, T., Murphy, P. L., Blaveri, E., McQuillin, A., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318788 · Cited by 373 · see citing works

Association and linkage analyses of RGS4 polymorphisms in schizophrenia

Chowdari, K. V. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.12.1373 · Cited by 368 · see citing works

Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex

Jasmin, L., Rabkin, S. D., Granato, A., Boudah, A., & Ohara, P. T. (2003) · Nature · doi:10.1038/nature01808 · Cited by 347 · see citing works

Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients

Takahashi, M., Shirakawa, O., Toyooka, K., Kitamura, N., Hashimoto, T., Maeda, K., Koizumi, S., Wakabayashi, K., Takahashi, H., Someya, T., et al. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000718 · Cited by 340 · see citing works

Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders

Iwamoto, K., Kakiuchi, C., Bundo, M., Ikeda, K., & Kato, T. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001437 · Cited by 331 · see citing works

The molecular genetics of schizophrenia: new findings promise new insights

Owen, M. J., Williams, N. M., & O’Donovan, M. C. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001444 · Cited by 322 · see citing works

Cell biology of the hippocampal formation in schizophrenia

Weinberger, D. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00331-x · Cited by 321 · see citing works

Diverse Psychotomimetics Act Through a Common Signaling Pathway

Svenningsson, P., Tzavara, E. T., Carruthers, R., Rachleff, I., Wattler, S., Nehls, M. C., McKinzie, D. L., Fienberg, A. A., Nomikos, G. G., & Greengard, P. (2003) · Science · doi:10.1126/science.1089681 · Cited by 313 · see citing works

Piecing together the Puzzle of Basal Forebrain Anatomy

Heimer, L., & Alheid, G. F. (1991) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4757-0145-6_1 · Cited by 310 · see citing works

Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease

Albers, D. S., & Beal, M. F. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_16 · Cited by 297 · see citing works

What Are the Right Targets for Psychopharmacology?

Hyman, S. E., & Fenton, W. S. (2003) · Science · doi:10.1126/science.1077141 · Cited by 282 · see citing works

A Genomewide Screen for Schizophrenia Genes in an Isolated Finnish Subpopulation, Suggesting Multiple Susceptibility Loci

Hovatta, I., Varilo, T., Suvisaari, J., Terwilliger, J. D., Ollikainen, V., Arajärvi, R., Juvonen, H., Kokko-Sahin, M.-L., Väisänen, L., Mannila, H., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302567 · Cited by 281 · see citing works

A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22

Kelsoe, J. R., Spence, M. A., Loetscher, E., Foguet, M., Sadovnick, A. D., Remick, R. A., Flodman, P. L., Khristich, J. V., Mroczkowski‐Parker, Z., Brown, J. L., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.585 · Cited by 275 · see citing works

Are schizophrenic and bipolar disorders related? A review of family and molecular studies

Berrettini, W. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00883-0 · Cited by 272 · see citing works

Endophenotypes in bipolar disorder

Lenox, R. H., Gould, T. D., & Manji, H. K. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10360 · Cited by 264 · see citing works

Cdk5-Mediated Inhibition of the Protective Effects of Transcription Factor MEF2 in Neurotoxicity-Induced Apoptosis

Gong, X., Tang, X., Wiedmann, M. W., Xuemin, W., Peng, J., Zheng, D., Blair, L. A. C., Marshall, J. J., & Mao, Z. (2003) · Neuron · doi:10.1016/s0896-6273(03)00191-0 · Cited by 260 · see citing works

Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus

Müller, M. B., Lucassen, P. J., Yassouridis, A., Hoogendijk, W. J. G., Holsboer, F., & Swaab, D. F. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01784.x · Cited by 249 · see citing works

Are Schizophrenic and Bipolar Disorders Related? A Review of Family and Molecular Studies

Berrettini, W. H. (2019) · Routledge eBooks · doi:10.4324/9781315054308-5 · Cited by 245 · see citing works

Gene Expression Profile for Schizophrenia

Hemby, S. E., Ginsberg, S. D., Brunk, B. P., Arnold, S. E., Trojanowski, J. Q., & Eberwine, J. H. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.7.631 · Cited by 234 · see citing works

Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac)

Svenningsson, P., Tzavara, E. T., Witkin, J. M., Fienberg, A. A., Nomikos, G. G., & Greengard, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052712799 · Cited by 229 · see citing works

22q11 deletion syndrome in adults with schizophrenia

Bassett, A. S., Hodgkinson, K. A., Chow, E. W. C., Correia, S., Scutt, L. E., & Weksberg, R. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980710)81:4 · Cited by 228 · see citing works

Brain SPECT Imaging of Amphetamine-Induced Dopamine Release in Euthymic Bipolar Disorder Patients

Anand, A., Verhoeff, P., Seneca, N., Zoghbi, S. S., Seibyl, J. P., Charney, D. S., & Innis, R. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.7.1108 · Cited by 222 · see citing works

BDNF: a neuromodulator in nociceptive pathways?

Pezet, S., Malcangio, M., & McMahon, S. B. (2002) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00206-0 · Cited by 218 · see citing works

Early accumulation of p62 in neurofibrillary tangles in Alzheimer's disease: possible role in tangle formation

Kuusisto, E., Salminen, A., & Alafuzoff, I. I. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.00394.x · Cited by 213 · see citing works

Anterior cingulate cortex pathology in schizophrenia and bipolar disorder

Bouras, C., Kövari, E., Hof, P. R., Riederer, B. M., & Giannakopoulos, P. (2001) · Acta Neuropathologica · doi:10.1007/s004010100392 · Cited by 208 · see citing works

Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia

Dean, B., McLeod, M., Keriakous, D., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001199 · Cited by 207 · see citing works

Identifying a series of candidate genes for mania and psychosis: a convergent functional genomics approach

Niculescu, A. B., Segal, D. S., Kuczenski, R. T., Barrett, T. B., Hauger, R. L., & Kelsoe, J. R. (2000) · Physiological Genomics · doi:10.1152/physiolgenomics.2000.4.1.83 · Cited by 206 · see citing works

Genome-wide scan for schizophrenia in the Finnish population: evidence for a locus on chromosome 7q22

Ekelund, J. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.7.1049 · Cited by 206 · see citing works

Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients

Koh, P., Undie, A. S., Kabbani, N., Levenson, R. G., Goldman, P. S., & Lidow, M. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232693499 · Cited by 202 · see citing works

N-Methyl- d -Aspartic Acid Receptor Expression in the Dorsolateral Prefrontal Cortex of Elderly Patients With Schizophrenia

Dracheva, S. M., Marras, S. A. E., Elhakem, S. L., Kramer, F. R., Davis, K. L., & Haroutunian, V. H. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1400 · Cited by 190 · see citing works

Antiapoptotic role of the p38 mitogen-activated protein kinase–myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation

Okamoto, S.-I., Krainc, D., Sherman, K., & Lipton, S. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130502697 · Cited by 188 · see citing works

Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia

Vawter, M. P., Thatcher, L. N., Usen, N., Hyde, T. M., Kleinman, J. E., & Freed, W. J. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001158 · Cited by 188 · see citing works

14-3-3 Proteins in Lewy Bodies in Parkinson Disease and Diffuse Lewy Body Disease Brains

Kawamoto, Y., Akiguchi, I., Nakamura, S., et al. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.3.245 · Cited by 181 · see citing works

Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine

Lindskog, M., Svenningsson, P., Pozzi, L., Kim, Y. D., Fienberg, A. A., Bibb, J. A., Fredholm, B. B., Nairn, A. C., Greengard, P., & Fisone, G. (2002) · Nature · doi:10.1038/nature00817 · Cited by 180 · see citing works

Evidence for Decreased DARPP-32 in the Prefrontal Cortex of Patients With Schizophrenia

Albert, K. A., Hemmings, H. C., Adamo, A. I. B., Potkin, S. G., Akbarian, S., Sandman, C. A., Cotman, C. W., Bunney, W. E., & Greengard, P. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.8.705 · Cited by 168 · see citing works

Neuropeptide Y and its receptors as potential therapeutic drug targets

Silva, A. P., Cavadas, C., & Grouzmann, E. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00301-7 · Cited by 166 · see citing works

Microarrays--Guilt by Association

Quackenbush, J. (2003) · Science · doi:10.1126/science.1090887 · Cited by 164 · see citing works

Neuronal expression of glutamine synthetase in Alzheimer’s disease indicates a profound impairment of metabolic interactions with astrocytes

Robinson, S. R. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(99)00150-3 · Cited by 163 · see citing works

Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis

Schwab, S. G., Eckstein, G., Hallmayer, J. F., et al. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000263 · Cited by 157 · see citing works

Attenuated 5‐HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3‐kinase, Akt and mitogen‐activated protein kinase

Hsiung, S., Adlersberg, M., Arango, V., Mann, J. J., Tamir, H., & Liu, K. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01987.x · Cited by 156 · see citing works

Regulation of DARPP‐32 dephosphorylation at PKA‐ and Cdk5‐sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase‐2A

Nishi, A., Bibb, J. A., Matsuyama, S., Hamada, M., Higashi, H., Nairn, A. C., & Greengard, P. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00876.x · Cited by 152 · see citing works

Diminished Anxiety- and Depression-Related Behaviors in Mice with Selective Deletion of theTac1Gene

Bilkei‐Gorzó, A., Rácz, I., Michel, K., & Zimmer, A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-22-10046.2002 · Cited by 152 · see citing works

The Genetics of Adult-Onset Neuropsychiatric Disease: Complexities and Conundra?

Kennedy, J. L., Farrer, L. A., Andreasen, N. C., Mayeux, R. P., & George‐Hyslop, P. S. (2003) · Science · doi:10.1126/science.1092132 · Cited by 149 · see citing works

DARPP-32 and regulation of the ethanol sensitivity of NMDA receptors in the nucleus accumbens

Maldve, R. E., Zhang, T. A., Ferrani-Kile, K., Schreiber, S. S., Lippmann, M. J., Snyder, G. L., Fienberg, A. A., Leslie, S. W., Gonzales, R. A., & Morrisett, R. A. (2002) · Nature Neuroscience · doi:10.1038/nn877 · Cited by 143 · see citing works

A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q

Cichon, S. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.25.2933 · Cited by 140 · see citing works

Requirement for DARPP-32 in Progesterone-Facilitated Sexual Receptivity in Female Rats and Mice

Mani, S. K., Fienberg, A. A., O'Callaghan, J. P., et al. (2000) · Science · doi:10.1126/science.287.5455.1053 · Cited by 134 · see citing works

Abnormalities in the synaptic vesicle fusion machinery in Huntington’s disease

Morton, A. J., Faull, R. L. M., & Edwardson, J. M. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00611-6 · Cited by 132 · see citing works

RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders

Iwamoto, K., & Kato, T. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00608-6 · Cited by 132 · see citing works

Suicide Risk and Treatments for Patients With Bipolar Disorder

Baldessarini, R. J. (2003) · JAMA · doi:10.1001/jama.290.11.1517 · Cited by 131 · see citing works

A genome-wide scan shows significant linkage between bipolar disorder and chromosome 12q24.3 and suggestive linkage to chromosomes 1p22–21, 4p16, 6q14–22, 10q26 and 16p13.3

Ewald, H., Flint, T. J., Kruse, T. A., & Mors, O. N. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001074 · Cited by 124 · see citing works

Evidence for a putative bipolar disorder locus on 2p13–16 and other potential loci on 4q31, 7q34, 8q13, 9q31, 10q21–24, 13q32, 14q21 and 17q11–12

Liu, J., Juo, S. H., DeWan, A. T., Grunn, A., Tong, X., Brito, M., Park, N., Loth, J. E., Kanyas, K., Lerer, B., et al. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001254 · Cited by 123 · see citing works

Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia.

Ross, B., Turenne, S., Moszczynska, A., Warsh, J., & Kish, S. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01123-3 · Cited by 120 · see citing works

Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system

Ralph, R. J., Paulus, M. P., Zhuang, X., Hen, R., & Geyer, M. A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01489-0 · Cited by 119 · see citing works

Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain

Pacheco, M. A., Stockmeier, C. A., Meltzer, H. Y., Overholser, J. C., Dilley, G. E., & Jope, R. S. (1996) · Brain Research · doi:10.1016/0006-8993(96)00207-7 · Cited by 118 · see citing works

Phospholipid‐Metabolizing Enzymes in Alzheimer's Disease: Increased Lysophospholipid Acyltransferase Activity and Decreased Phospholipase A2 Activity

Ross, B. M., Moszczyńska, A., Erlich, J. C., & Kish, S. J. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70020786.x · Cited by 118 · see citing works

Behavioral organization is independent of locomotor activity in 129 and C57 mouse strains1Published on the World Wide Web on 16 February 1999.1

Paulus, M. P., Dulawa, S. C., Ralph, R. J., & Geyer, M. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01137-3 · Cited by 117 · see citing works

Casein kinase 1 delta mRNA is upregulated in Alzheimer disease brain

Yasojima, K., Kuret, J., DeMaggio, A. J., McGeer, E. G., & McGeer, P. L. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02200-9 · Cited by 116 · see citing works

Glycogen synthase kinase-3β immunoreactivity is reduced in the prefrontal cortex in schizophrenia

Beasley, C. L., Cotter, D., Khan, N., Pollard, C., Sheppard, P. W., Varndell, I. M., Lovestone, S., Anderton, B. H., & Everall, I. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01688-3 · Cited by 115 · see citing works

Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia.

Laakso, A., Bergman, J., Haaparanta, M., Vilkman, H., Solin, O., Syvälahti, E., & Hietala, J. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00095-5 · Cited by 113 · see citing works

Rapid-onset dystonia-parkinsonism

Pittock, S. J., Joyce, C. M., O’Keane, V., et al. (2000) · Neurology · doi:10.1212/wnl.55.7.991 · Cited by 112 · see citing works

Cannabinoid Withdrawal Syndrome Is Reduced in Pre-Proenkephalin Knock-Out Mice

Valverde, O., Maldonado, R. J., Valjent, E., Zimmer, A. M., & Zimmer, A. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09284.2000 · Cited by 110 · see citing works

A search for specific and common susceptibility loci for schizophrenia and bipolar disorder: a linkage study in 13 target chromosomes

Maziade, M., Roy, M.-A., Rouillard, E., Bissonnette, L., Fournier, J.-P., Roy, A., Garneau, Y., Montgrain, N., Potvin, A., Cliche, D., et al. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000915 · Cited by 107 · see citing works

Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder

Mundo, E., Tharmalingham, S., Neves-Pereira, M., Dalton, E. J., Macciardi, F. M., Parikh, S. V., Bolonna, A. A., Kerwin, R. W., Arranz, M. J., MAKOFF, A. J., et al. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001218 · Cited by 105 · see citing works

Genomewide Linkage Scan for Schizophrenia Susceptibility Loci among Ashkenazi Jewish Families Shows Evidence of Linkage on Chromosome 10q22

Fallin, M. D., Lasseter, V. K., Wolyniec, P. S., McGrath, J. A., Nestadt, G., Valle, D. L., Liang, K., & Pulver, A. E. (2003) · The American Journal of Human Genetics · doi:10.1086/378158 · Cited by 105 · see citing works

Analysis of the monoamine oxidase A (MAOA) gene in bipolar affective disorder by association studies, meta-analyses, and sequencing of the promoter

Furlong, R. A., Ho, L. W., Rubinsztein, J. S., Walsh, C., Paykel, E. S., & Rubinsztein, D. C. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990820)88:4 · Cited by 100 · see citing works

Characterization of a Neurotrophin Signaling Mechanism that Mediates Neuron Survival in a Temporally Specific Pattern

Shalizi, A., Lehtinen, M. K., Gaudilliere, B. L., Donovan, N., Han, J., Konishi, Y., & Bonni, A. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-19-07326.2003 · Cited by 97 · see citing works

Manic-depression genes and the new millennium: poised for discovery

Baron, M. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000998 · Cited by 95 · see citing works

Molecular Mechanisms Underlying Mood Stabilization in Manic-Depressive Illness: The Phenotype Challenge

Ikonomov, O. C., & Manji, H. K. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.10.1506 · Cited by 94 · see citing works

Glutamine synthetase and glutamate dehydrogenase in the prefrontal cortex of patients with schizophrenia

Burbaeva, G. S., Бокша, И. С., Turishcheva, M. S., Vorobyeva, E. A., Savushkina, O. K., & Терешкина, Е. Б. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00078-2 · Cited by 91 · see citing works

Myocyte-specific enhancer binding factor 2C expression in human brain development

Leifer, D., Golden, J. A., & Kowall, N. W. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90573-8 · Cited by 89 · see citing works

Levels of mRNAs encoding synaptic vesicle and synaptic plasma membrane proteins in the temporal cortex of elderly schizophrenic patients.

Sokolov, B., Tcherepanov, A., Haroutunian, V., & Davis, K. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00875-1 · Cited by 88 · see citing works

Up-regulation of metabotropic glutamate receptor subtypes 3 and 5 in spinal cord in a clinical model of persistent inflammation and hyperalgesia

Dolan, S., Kelly, J. G., Monteiro, A., & Nolan, A. M. (2003) · Pain · doi:10.1016/j.pain.2003.09.017 · Cited by 85 · see citing works

Neuronal and behavioural abnormalities in striatal function in DARPP‐32‐mutant mice

Hiroi, N., Fienberg, A. A., Haile, C. N., Alburges, M. E., Hanson, G. R., Greengard, P., & Nestler, E. J. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00570.x · Cited by 81 · see citing works

Abnormal Kainate Receptor Expression in Prefrontal Cortex in Schizophrenia

Meador‐Woodruff, J. H. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00189-5 · Cited by 80 · see citing works

Frequent deletions at Xq28 indicate genetic heterogeneity in Hunter syndrome

Wilson, P., Suthers, G. K., Callen, D. F., et al. (1991) · Human Genetics · doi:10.1007/bf00194643 · Cited by 78 · see citing works

Glutamate transport, glutamine synthetase and phosphate‐activated glutaminase in rat CNS white matter. A quantitative study

Hassel, B., Boldingh, K. A., Morland, C., et al. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01984.x · Cited by 75 · see citing works

Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics

Bachus, S. E., Hyde, T. M., Herman, M. M., Egan, M. F., & Kleinman, J. E. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(96)00041-6 · Cited by 74 · see citing works

A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19

Badenhop, R. F., Moses, M. J., Scimone, A., Mitchell, P. B., Ewen-White, K. R., Rosso, A., Donald, J. A., Adams, L. J., & Schofield, P. R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001025 · Cited by 73 · see citing works

Glycogen synthase kinase 3 alteration in alzheimer disease is related to neurofibrillary tangle formation

Baum, L., Hansen, L. A., Masliah, E., & Saitoh, T. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815006 · Cited by 71 · see citing works

Levels of ??-secretase BACE and ??-secretase ADAM10 mRNAs in Alzheimer hippocampus

Gatta, L. B., Albertini, A., Ravid, R., & Finazzi, D. (2002) · Neuroreport · doi:10.1097/00001756-200211150-00008 · Cited by 68 · see citing works

Neuropeptide Y Y1 and Y2 Receptor mRNA Expression in the Prefrontal Cortex of Psychiatric Subjects Relationship of Y2 Subtype to Suicidal Behavior

Caberlotto, L. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00231-1 · Cited by 67 · see citing works

Glycogen synthase kinase-3β, β-catenin, and tau in postmortem bipolar brain

Lesort, M. J., Greendorfer, A., Stockmeier, C. A., Johnson, G. V. W., & Jope, R. S. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050235 · Cited by 62 · see citing works

A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19

Badenhop, R. F., Moses, M. J., Scimone, A., Mitchell, P. B., Ewen-White, K. R., Rosso, A., Donald, J. A., Adams, L. J., & Schofield, P. R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001114 · Cited by 61 · see citing works

Regulation of AMPA receptor dephosphorylation by glutamate receptor agonists

Snyder, G. L., Galdi, S., Fienberg, A. A., Allen, P. B., Nairn, A. C., & Greengard, P. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00319-8 · Cited by 59 · see citing works

St John's wort and imipramine-induced gene expression profiles identify cellular functions relevant to antidepressant action and novel pharmacogenetic candidates for the phenotype of antidepressant treatment response

Wong, M.-L., O'Kirwan, F., HANNESTAD, J., Irizarry, K. J. L., Elashoff, D. A., & Licinio, J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001470 · Cited by 58 · see citing works

MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients

Molnar, M., Potkin, S. G., Bunney, W. E., & Jones, E. G. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01456-7 · Cited by 56 · see citing works

mRNA and Protein Expression of Selective Alpha Subunits of G Proteins are Abnormal in Prefrontal Cortex of Suicide Victims

Dwivedi, Y. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00335-4 · Cited by 55 · see citing works

Synaptosomal Proteins, Beta-Soluble N-Ethylmaleimide-Sensitive Factor Attachment Protein (Beta-SNAP), Gamma-SNAP and Synaptotagmin I in Brain of Patients with Down Syndrome and Alzheimer’s Disease

Yoo, B. C., Cairns, N. J., Fountoulakis, M., & Lübec, G. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051261 · Cited by 54 · see citing works

Global expression-profiling studies and oligodendrocyte dysfunction in schizophrenia and bipolar disorder

Davis, K. L., & Haroutunian, V. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14297-3 · Cited by 53 · see citing works

Hyperalgesia During Opioid Abstinence: Mediation by Glutamate and Substance P

Li, X., & Clark, J. D. (2002) · Anesthesia & Analgesia · doi:10.1097/00000539-200210000-00035 · Cited by 51 · see citing works

Cholecystokinin in CSF from depressed patients: possible relations to severity of depression and suicidal behaviour

Löfberg, C., Ågren, H., Harro, J., & Oreland, L. (1998) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)00046-1 · Cited by 51 · see citing works

Neurokinin-1 receptors are decreased in major depressive disorder

Stockmeier, C. A., Shi, X., Konick, L. C., et al. (2002) · Neuroreport · doi:10.1097/00001756-200207020-00031 · Cited by 51 · see citing works

Reduction of the synaptophysin level but normal levels of glycerophospholipids in the gyrus cinguli in schizophrenia

Landén, M., Davidsson, P., Gottfries, C., Månsson, J., & Blennow, K. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00197-9 · Cited by 49 · see citing works

Downregulation of Neuronal cdk5/p35 in Opioid Addicts and Opiate-Treated Rats: Relation to Neurofilament Phosphorylation

Ferrer‐Alcón, M., Harpe, R. L., Guimón, J., & Garcı́a-Sevilla, J. A. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300095 · Cited by 49 · see citing works

μ‐ and δ‐opioid receptor agonists inhibit DARPP‐32 phosphorylation in distinct populations of striatal projection neurons

Lindskog, M., Svenningsson, P., Fredholm, B. B., Greengard, P., & Fisone, G. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00597.x · Cited by 45 · see citing works

Genome wide scan using homozygosity mapping and linkage analyses of a single pedigree with affective disorder suggests oligogenic inheritance

Ewald, H., Kruse, T. A., & Mors, O. N. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20039 · Cited by 45 · see citing works

Genome scan of a second wave of NIMH genetics initiative bipolar pedigrees: chromosomes 2, 11, 13, 14, and X

Zandi, P. P., Willour, V. L., Huo, Y., et al. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.10063 · Cited by 45 · see citing works

Time-Dependent Alterations in ICSS Thresholds Associated With Repeated Amphetamine Administrations

Lin, D. C.-H. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00213-0 · Cited by 44 · see citing works

Mucopolysaccharidosis VII: postmortem biochemical and pathological findings in a young adult with beta-glucuronidase deficiency.

Vogler, C. A., Levy, B. K., Kyle, J. W., et al. (1994) · PubMed · Cited by 42 · see citing works

Genome scan of the fifty‐six bipolar pedigrees from the NIMH genetics initiative replication sample: Chromosomes 4, 7, 9, 18, 19, 20, and 21

Willour, V. L., Zandi, P. P., Huo, Y., et al. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20051 · Cited by 39 · see citing works

Regulation by the neuropeptide cholecystokinin (CCK-8S) of protein phosphorylation in the neostriatum.

Snyder, G. L., Fisone, G., Morino, P., Gundersen, V., Ottersen, O. P., Hökfelt, T. G. M., & Greengard, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11277 · Cited by 37 · see citing works

Acute and maintenance treatment with mood stabilizers

Bowden, C. L. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003535 · Cited by 34 · see citing works

Hyperalgesia During Opioid Abstinence: Mediation by Glutamate and Substance P

Li, X., & Clark, J. D. (2002) · Anesthesia & Analgesia · doi:10.1213/00000539-200210000-00035 · Cited by 34 · see citing works

Decreased prostaglandin synthesis in postmortem cerebral cortex from patients with Alzheimer's disease

Wong, P. T. ‐., McGeer, P. L., & McGeer, E. G. (1992) · Neurochemistry International · doi:10.1016/0197-0186(92)90147-j · Cited by 31 · see citing works

Substance P and Affective Disorders: New Treatment Opportunities by Neurokinin 1 Receptor Antagonists?

Lieb, K., Treffurth, Y., Berger, T., & Fiebich, B. L. (2002) · Neuropsychobiology · doi:10.1159/000049254 · Cited by 31 · see citing works

Cannabis-sensitive dopaminergic markers in postmortem central nervous system: changes in schizophrenia

Dean, B., Bradbury, R., & Copolov, D. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01545-7 · Cited by 30 · see citing works

Further postmortem autoradiographic studies of AMPA receptor binding in schizophrenia

Noga, J. T., & Wang, H. (2002) · Synapse · doi:10.1002/syn.10106 · Cited by 28 · see citing works

An N-terminal fragment of ProSAAS (a granin-like neuroendocrine peptide precursor) is associated with tau inclusions in Pick’s disease

Kikuchi, K., Arawaka, S., Koyama, S., Kimura, H., Ren, C.-H., Wada, M., Kawanami, T., Kurita, K., Daimon, M., Kawakatsu, S., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01391-3 · Cited by 28 · see citing works

The association of the D2S2944 124 bp allele with recurrent early onset major depressive disorder in women

Philibert, R. A., Caspers, K. M., Langbehn, D. R., Troughton, E. P., Yucuis, R., Sandhu, H. K., & Cadoret, R. J. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20062 · Cited by 28 · see citing works

Increased tachykinin NK1 receptor immunoreactivity in the prefrontal cortex in schizophrenia

Tooney, P. A., Crawter, V. C., & Chahl, L. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01068-4 · Cited by 28 · see citing works

Enkephalin, dynorphin and substance P in postmortem substantia nigra from normals and schizophrenic patients

Iadarola, M. J., Ofri, D., & Kleinman, J. E. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90224-y · Cited by 26 · see citing works

Lithium and valproate protect against dextro-amphetamine induced brain choline concentration changes in bipolar disorder patients

Silverstone, P. H., Asghar, S., O'Donnell, T., Ulrich, M., & Hanstock, C. C. (2004) · The World Journal of Biological Psychiatry · doi:10.1080/15622970410029906 · Cited by 23 · see citing works

Cholecystokinin Antagonists A New Way to Improve the Analgesia from Old Analgesics?

McCleane, G. J. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043386419 · Cited by 22 · see citing works

Tau protein expression in frontotemporal dementias.

Adamec, E., Chang, H. T., Stopa, E., Hedreen, J., & Vonsattel, J. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02314-x · Cited by 22 · see citing works

Neuroleukin inhibition sensitises neuronal cells to caspase-dependent apoptosis

Romagnoli, A., Oliverio, S., Evangelisti, C., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00188-8 · Cited by 22 · see citing works

Finding Genes for Bipolar Disorder in the Functional Genomics Era: From Convergent Functional Genomics to Phenomics and Back

Niculescu, A. B., & Kelsoe, J. R. (2002) · CNS Spectrums · doi:10.1017/s1092852900017582 · Cited by 21 · see citing works

Carbamazepine Suppresses Methamphetamine-Induced Fos Expression in a Regionally Specific Manner in the Rat Brain Possible Neural Substrates Responsible for Antimanic Effects of Mood Stabilizers

Lee, Y. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00142-6 · Cited by 18 · see citing works

A linkage disequilibrium study of bipolar disorder and microsatellite markers on 22q13

Liang, S. G., Sadovnick, A. D., Remick, R. A., et al. (2002) · Psychiatric Genetics · doi:10.1097/00041444-200212000-00006 · Cited by 13 · see citing works

Differential regional zif268 messenger RNA expression in an escalating dose/binge model of amphetamine-induced psychosis

Shilling, P. D., Kelsoe, J. R., Kuczenski, R. T., et al. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00510-2 · Cited by 11 · see citing works

The Human Genome: Genetic Testing and Animal Models

Niculescu, A. B., & Kelsoe, J. R. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1587 · Cited by 7 · see citing works

Rapid Publication Genome Scan of the Fifty-Six Bipolar Pedigrees From the NIMH Genetics Initiative Replication Sample: Chromosomes 4, 7, 9, 18, 19, 20, and 21

Willour, V. L., Zandi, P. P., Huo, Y., et al. (2003) · Cited by 1 · see citing works

Untitled work

Jonnal (2000) · doi:10.1002/1096-8628(20001204)96:6

Mania-like behavior induced by disruption of <i>CLOCK</i>

Roybal, K., Theobold, D., Graham, A., DiNieri, J. A., Russo, S. J., Krishnan, V., Chakravarty, S., Peevey, J., Oehrlein, N., Birnbaum, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609625104 · Cited by 803 · see citing works

Circadian genes, rhythms and the biology of mood disorders

McClung, C. A. (2007) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2007.02.003 · Cited by 666 · see citing works

Toward constructing an endophenotype strategy for bipolar disorders

Hasler, G., Drevets, W. C., Gould, T. D., Gottesman, I. I., & Manji, H. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.006 · Cited by 423 · see citing works

Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression

Guilloux, J.-P., Douillard-Guilloux, G., Kota, R., Wang, X., Gardier, A. M., Martinowich, K., Tseng, G. C., Lewis, D. A., & Sibille, E. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.113 · Cited by 378 · see citing works

Neuroplasticity Mediated by Altered Gene Expression

McClung, C. A., & Nestler, E. J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301544 · Cited by 347 · see citing works

Convergent functional genomics of genome‐wide association data for bipolar disorder: Comprehensive identification of candidate genes, pathways and mechanisms

Le‐Niculescu, H., Patel, S. D., Bhat, M., Kuczenski, R., Faraone, S. V., Tsuang, M. T., McMahon, F. J., Schork, N. J., Nurnberger, J. I., & Niculescu, A. B. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30887 · Cited by 201 · see citing works

Discovery and validation of blood biomarkers for suicidality

Le-Niculescu, H., Levey, D. F., Ayalew, M., Palmer, L., Gavrin, L. M., Jain, N., Winiger, E., Bhosrekar, S., Shankar, G., Radel, M., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.95 · Cited by 193 · see citing works

The circadian basis of mood disorders: Recent developments and treatment implications

Monteleone, P., & Maj, M. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.06.007 · Cited by 185 · see citing works

Towards understanding the schizophrenia code: an expanded convergent functional genomics approach

Le‐Niculescu, H., Balaraman, Y., Patel, S., Tan, J., Sidhu, K., Jerome, R. E., Edenberg, H. J., Kuczenski, R., Geyer, M. A., Nurnberger, J. I., et al. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30481 · Cited by 137 · see citing works

Assessment of circadian function in fibroblasts of patients with bipolar disorder

Yang, S., Van Dongen, H. P. A., Wang, K., Berrettini, W., & Bućan, M. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.10 · Cited by 113 · see citing works

Sleep- and circadian rhythm–associated pathways as therapeutic targets in bipolar disorder

Bellivier, F., Geoffroy, P.-A., Etain, B., & Scott, J. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1018822 · Cited by 104 · see citing works

Deletion of the life span determinant p66Shc prevents age-dependent increases in emotionality and pain sensitivity in mice

Berry, A., Capone, F., Giorgio, M., Pelicci, P. G., de Kloet, E. R., Alleva, E., Minghetti, L., & Cirulli, F. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2006.05.018 · Cited by 81 · see citing works

Reverse translational strategies for developing animal models of bipolar disorder

Malkesman, O., Austin, D. R., Chen, G., & Manji, H. K. (2009) · Disease Models &amp; Mechanisms · doi:10.1242/dmm.001628 · Cited by 70 · see citing works

DRD2 and PPP1R1B (DARPP-32) polymorphisms independently confer increased risk for autism spectrum disorders and additively predict affected status in male-only affected sib-pair families

Hettinger, J. A., Liu, X., Hudson, M. L., Lee, A., Cohen, I. L., Michaelis, R. C., Schwartz, C. E., Lewis, S. M., & Holden, J. J. (2012) · Behavioral and Brain Functions · doi:10.1186/1744-9081-8-19 · Cited by 68 · see citing works

Common Genetic Variants and Gene-Expression Changes Associated with Bipolar Disorder Are Over-Represented in Brain Signaling Pathway Genes

Pedroso, I., Lourdusamy, A., Rietschel, M., Nöthen, M. M., Cichon, S., McGuffin, P., Al-Chalabi, A., Barnes, M. R., & Breen, G. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.031 · Cited by 59 · see citing works

Role for the<i>Clock</i>Gene in Bipolar Disorder

McClung, C. A. (2007) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2007.72.031 · Cited by 57 · see citing works

Circadian rhythm hypotheses of mixed features, antidepressant treatment resistance, and manic switching in bipolar disorder

Lee, H.-J., Son, G.-H., & Geum, D. (2013) · Psychiatry Investigation · doi:10.4306/pi.2013.10.3.225 · Cited by 48 · see citing works

Monoaminergic Synapses in the Brain : Regulation and Ontogenetic Development

Nomura, Y. (1982) · YAKUGAKU ZASSHI · doi:10.1248/yakushi1947.102.7_603 · Cited by 1 · see citing works

Development of Monoaminergic Transmissions in the Rat Brain

Renson, J. (1971) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-7236-3_14 · Cited by 14 · see citing works

Rapid-onset antidepressant efficacy of glutamatergic system modulators：The neural plasticity hypothesis of depression

Jing, Wang, Liang, L., et al. (2015) · Acta Scientiarum Naturalium Universitatis Sunyatseni

[Monoaminergic theories in depressive illness (author's transl)].

Zarifian, E. (1979) · PubMed

Cellular consequences of stress and depression

Fuchs, E., & Flügge, G. (2004) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2004.6.2/efuchs · Cited by 29 · see citing works